Compound ID | 823

VRC-3406

Class: Oxazolidinone

Spectrum of activity: Gram-negative
Institute where first reported: Versicor Inc. (Pfizer, USA)
Year first mentioned: 2000
Highest developmental phase: Preclinical
Development status: Inactive
Reason Dropped: Pfizer had linezolid. None of these had advantages (LS)
Chemical structure(s):
Click here for structure editor
Molecular weight: 412.42
Iso. SMILES: CC(=O)NC[C@H]1CN(C(=O)O1)C2=CC(=C(C=C2)SC3=NC=C(S3)[N+](=O)[O-])F
InChI Key: GSKGEKSUJQNXPJ-JTQLQIEISA-N
Can. SMILES: CC(=O)NC[C@H]1CN(C2=CC=C(C(=C2)F)SC3=NC=C([N+](=O)[O-])S3)C(=O)O1
InChI: InChI=1S/C15H13FN4O5S2/c1-8(21)17-5-10-7-19(15(22)25-10)9-2-3-12(11(16)4-9)26-14-18-6-13(27-14)20(23)24/h2-4,6,10H,5,7H2,1H3,(H,17,21)/t10-/m0/s1
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/485764
Citation:

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.